Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit.
Algera MD, van Driel WJ, Slangen BFM, Wouters MWJM, Kruitwagen RFPM; participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Gynecol Oncol. 2024 Jul;186:144-153. doi: 10.1016/j.ygyno.2024.04.002. Epub 2024 Apr 30. Gynecol Oncol. 2024. PMID: 38688188 Free article.
Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the 'Dutch Gynecological Oncology Audit'.
Algera MD, van Driel WJ, Slangen BFM, Kruitwagen RFPM, Wouters MWJM; participants of the Dutch Gynecological Oncology Collaborator group. Algera MD, et al. Gynecol Oncol. 2022 May;165(2):330-338. doi: 10.1016/j.ygyno.2022.02.013. Epub 2022 Feb 22. Gynecol Oncol. 2022. PMID: 35221132 Free PMC article.
Clinical implementation of routine diagnostic laparoscopy to guide initial treatment in patients with advanced-stage epithelial ovarian cancer in Dutch clinical practice: Evaluation of support and a budget impact analysis.
Lof P, Retèl VP, Algera MD, van Gent MDJM, Gaarenstroom KN, van Driel WJ. Lof P, et al. Among authors: algera md. Gynecol Oncol. 2022 Jun;165(3):459-465. doi: 10.1016/j.ygyno.2022.03.028. Epub 2022 Apr 9. Gynecol Oncol. 2022. PMID: 35414427
Case-mix adjustment to compare hospital performances regarding complications after cytoreductive surgery for ovarian cancer: a nationwide population-based study.
Algera MD, Baldewpersad Tewarie NMS, Driel WJV, van Ham MAPC, Slangen BFM, Kruitwagen RFPM, Wouters MWJM; Participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Int J Gynecol Cancer. 2023 Apr 3;33(4):534-542. doi: 10.1136/ijgc-2022-003981. Int J Gynecol Cancer. 2023. PMID: 36581486
Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study.
Algera MD, Slangen BFM, van Driel WJ, Wouters MWJM, Kruitwagen RFPM; participants of the Dutch Gynecological Oncology Audit Collaborator Group. Algera MD, et al. Gynecol Oncol. 2023 Jul;174:89-97. doi: 10.1016/j.ygyno.2023.04.021. Epub 2023 May 9. Gynecol Oncol. 2023. PMID: 37167897 Free article.
Exploring international differences in ovarian cancer care: a survey report on global patterns of care, current practices, and barriers.
Algera MD, Morton R, Sundar SS, Farrell R, van Driel WJ, Brennan D, Rijken MJ, Sfeir S, Allen L, Eiken M, Coleman RL; collaborators of the Global Equality in Ovarian Cancer Care project group. Algera MD, et al. Int J Gynecol Cancer. 2023 Oct 2;33(10):1612-1620. doi: 10.1136/ijgc-2023-004563. Int J Gynecol Cancer. 2023. PMID: 37591611 Free PMC article.
Exploring global barriers to optimal ovarian cancer care: thematic analysis.
Sfeir S, Allen L, Algera MD, Morton R, Farrell R, Brennan D, Driel WJV, Rijken MJ, Eiken M, Sundar SS, Coleman RL; collaborators of the Global Equality in Ovarian Cancer Care project group. Sfeir S, et al. Among authors: algera md. Int J Gynecol Cancer. 2024 Sep 2;34(9):1408-1415. doi: 10.1136/ijgc-2024-005449. Int J Gynecol Cancer. 2024. PMID: 38821547